Abrogation of resistance to foreign bone marrow grafts by carrageenans. I. Studies with the anti-macrophage agent seakem carrageenan.
D000818:Animals; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D002351:Carrageenan / Q000008:administration & dosage / Q000494:pharmacology*; D004357:Drug Synergism; D005260:Female; D006084:Graft Rejection / Q000187:drug effects*; D008264:Macrophages / Q000187:drug effects / Q000276:immunology; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D011144:Polyvinylpyridine N-Oxide / Q000494:pharmacology; D011828:Radiation Chimera; D051381:Rats; D011919:Rats, Inbred Strains; D012822:Silicon Dioxide / Q000008:administration & dosage / Q000494:pharmacology; D014183:Transplantation, Heterologous; D014184:Transplantation, Homologous; D014185:Transplantation, Isogeneic
D012822:Silicon Dioxide; D002351:Carrageenan; D011144:Polyvinylpyridine N-Oxide